A detailed history of Rock Springs Capital Management LP transactions in Gossamer Bio, Inc. stock. As of the latest transaction made, Rock Springs Capital Management LP holds 3,266,960 shares of GOSS stock, worth $2.29 Million. This represents 0.11% of its overall portfolio holdings.

Number of Shares
3,266,960
Previous 3,266,960 -0.0%
Holding current value
$2.29 Million
Previous $2.94 Million 10.0%
% of portfolio
0.11%
Previous 0.09%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2023

Nov 14, 2023

BUY
$0.78 - $1.82 $1.69 Million - $3.94 Million
2,166,686 Added 196.92%
3,266,960 $2.71 Million
Q1 2023

May 15, 2023

BUY
$0.96 - $2.92 $695,256 - $2.11 Million
724,226 Added 192.59%
1,100,274 $1.39 Million
Q4 2022

Feb 14, 2023

SELL
$1.74 - $12.87 $2.11 Million - $15.6 Million
-1,210,914 Reduced 76.3%
376,048 $816,000
Q3 2022

Nov 14, 2022

BUY
$7.21 - $14.88 $11.4 Million - $23.6 Million
1,586,962 New
1,586,962 $19 Million

Others Institutions Holding GOSS

About Gossamer Bio, Inc.


  • Ticker GOSS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 93,954,000
  • Market Cap $65.8M
  • Description
  • Gossamer Bio, Inc., a clinical-stage biopharmaceutical company, focuses on discovering, acquiring, developing, and commercializing therapeutics in the disease areas of immunology, inflammation, and oncology in the United States. The company is developing GB002, an inhaled, small molecule, platelet-derived growth factor receptor, or PDGFR, colony...
More about GOSS
Track This Portfolio

Track Rock Springs Capital Management LP Portfolio

Follow Rock Springs Capital Management LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Rock Springs Capital Management LP, based on Form 13F filings with the SEC.

News

Stay updated on Rock Springs Capital Management LP with notifications on news.